S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
pixel
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
pixel
NASDAQ:PROF

Profound Medical (PROF) Stock Forecast, Price & News

$7.38
-1.92 (-20.65%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.07
$8.96
50-Day Range
$6.91
$9.53
52-Week Range
$6.09
$17.74
Volume
124,831 shs
Average Volume
14,019 shs
Market Capitalization
$153.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.50

Profound Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
96.5% Upside
$14.50 Price Target
Short Interest
Bearish
2.42% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.17mentions of Profound Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.37) to ($1.06) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

796th out of 1,283 stocks

Surgical & Medical Instruments Industry

83rd out of 130 stocks

Profound Medical logo

About Profound Medical (NASDAQ:PROF) Stock

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Alliance Global Partners cut their price target on shares of Profound Medical from $16.25 to $12.00 and set a "buy" rating for the company in a report on Tuesday, May 10th. Raymond James cut their price target on shares of Profound Medical from $22.00 to $17.50 and set an "outperform" rating for the company in a report on Monday, July 18th.

Profound Medical Price Performance

NASDAQ:PROF traded down $1.92 on Friday, reaching $7.38. The company's stock had a trading volume of 124,831 shares, compared to its average volume of 14,019. Profound Medical has a twelve month low of $6.09 and a twelve month high of $17.74. The firm's 50 day moving average is $8.03 and its two-hundred day moving average is $8.48.

Profound Medical (NASDAQ:PROF - Get Rating) last posted its quarterly earnings data on Monday, May 9th. The company reported ($0.40) EPS for the quarter, beating analysts' consensus estimates of ($0.45) by $0.05. Profound Medical had a negative net margin of 437.62% and a negative return on equity of 37.39%. The company had revenue of $1.36 million during the quarter, compared to analyst estimates of $1.50 million. As a group, analysts expect that Profound Medical will post -1.37 earnings per share for the current fiscal year.

Receive PROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PROF Stock News Headlines

Recap: Profound Medical Q2 Earnings
Profound Medical (NASDAQ:PROF) PT Lowered to $17.50
TULSA-PRO® Was Front and Center at AUA2022
Earnings Outlook For Profound Medical
Doctors suggest new names for low-grade prostate cancer
Medical experts discuss long haul COVID
Recap: Profound Medical Q4 Earnings
See More Headlines

Receive PROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PROF Company Calendar

Last Earnings
5/09/2022
Today
8/07/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PROF
Employees
146
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.50
High Stock Price Forecast
$17.50
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+96.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-30,700,000.00
Net Margins
-437.62%
Pretax Margin
-415.97%

Debt

Sales & Book Value

Annual Sales
$6.87 million
Book Value
$3.88 per share

Miscellaneous

Free Float
N/A
Market Cap
$153.87 million
Optionable
Optionable
Beta
1.25

Key Executives

  • Dr. Arun Swarup Menawat MBA (Age 67)
    Ph.D., Chairman & CEO
    Comp: $3.08M
  • Mr. Rashed Dewan (Age 54)
    Chief Financial Officer
    Comp: $198.13k
  • Dr. Mathieu Burtnyk (Age 40)
    Sr. VP of Product Leader TULSA-PRO
    Comp: $221.27k
  • Mr. Stephen Kilmer
    Investor Relations
  • Mr. Jacques F. Cornet (Age 66)
    Sr. VP & Product Leader Sonalleve
  • Mr. Michael Mydra
    VP & Head of Global Market Access
  • Mr. Kenneth Knudson
    Chief Commercial Officer
  • Mr. Matthew Sobczyk C.A.
    CPA, Assistant Corp. Controller
  • Mr. Levant Tinaz
    Software Developer













PROF Stock - Frequently Asked Questions

Should I buy or sell Profound Medical stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Profound Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Profound Medical stock.
View analyst ratings for Profound Medical
or view top-rated stocks.

What is Profound Medical's stock price forecast for 2022?

3 equities research analysts have issued 1-year target prices for Profound Medical's shares. Their PROF stock forecasts range from $12.00 to $17.50. On average, they expect Profound Medical's stock price to reach $14.50 in the next twelve months. This suggests a possible upside of 96.5% from the stock's current price.
View analysts' price targets for Profound Medical
or view top-rated stocks among Wall Street analysts.

How has Profound Medical's stock performed in 2022?

Profound Medical's stock was trading at $11.23 at the beginning of the year. Since then, PROF shares have decreased by 34.3% and is now trading at $7.38.
View the best growth stocks for 2022 here
.

When is Profound Medical's next earnings date?

Profound Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our earnings forecast for Profound Medical
.

How were Profound Medical's earnings last quarter?

Profound Medical Corp. (NASDAQ:PROF) posted its quarterly earnings data on Monday, May, 9th. The company reported ($0.40) earnings per share for the quarter, beating analysts' consensus estimates of ($0.45) by $0.05. The business earned $1.36 million during the quarter, compared to analysts' expectations of $1.50 million. Profound Medical had a negative trailing twelve-month return on equity of 37.39% and a negative net margin of 437.62%.

What is Profound Medical's stock symbol?

Profound Medical trades on the NASDAQ under the ticker symbol "PROF."

Who are Profound Medical's major shareholders?

Profound Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Gagnon Securities LLC (6.37%), Timelo Investment Management Inc. (4.04%), Royce & Associates LP (2.41%), Zweig DiMenna Associates LLC (1.23%), National Bank of Canada FI (0.57%) and Thompson Davis & CO. Inc. (0.37%).

How do I buy shares of Profound Medical?

Shares of PROF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Profound Medical's stock price today?

One share of PROF stock can currently be purchased for approximately $7.38.

How much money does Profound Medical make?

Profound Medical (NASDAQ:PROF) has a market capitalization of $153.87 million and generates $6.87 million in revenue each year. The company earns $-30,700,000.00 in net income (profit) each year or ($1.46) on an earnings per share basis.

How many employees does Profound Medical have?

Profound Medical employs 146 workers across the globe.

How can I contact Profound Medical?

Profound Medical's mailing address is 2400 SKYMARK AVENUE UNIT 6, MISSISSAUGA A6, L4W 5K5. The official website for Profound Medical is www.profoundmedical.com. The company can be reached via phone at (647) 476-1350, via email at skilmer@profoundmedical.com, or via fax at 64-7847-3739.

This page (NASDAQ:PROF) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.